Monday, March 7, 2016

Basket Donation Sign up!

Please click the link if you or a group would like to donate a chinese auction basket for the April 25th golf tournament! Basket donation sign up

Monday, March 7, 2016

Golf Tournament 2016- Corporate Sponsorship

Corporate Sponsorship information! Your business can sponsor a hole sign, have their logo on every cart, or you can have an "In loving memory" sign on one of the holes. Click the link for the flyer! CORPORATE 2016 POWCOR
Corporate Sponsorship

Monday, March 7, 2016

Golf Tournament 2016

We are back! April 25, 2016 we are having our annual golf tournament at Running Deer! Registration is below! Click the link to view the flyer for further details! Golf_Flyer 2016
Golfer Registration

Saturday, February 21, 2015

Support Powcor just by shopping on Amazon!

Powcor invites you to support our organization by shopping at AmazonSmile. Amazon will donate .5% of your purchases to Powcor, with no cost to you (aside from all the things you are already buying on Amazon)! You just shop on Amazon as you typically do and Amazon will do the rest! The link below will connect you directly to in support of our organization. Thanks everyone!! Every little bit helps :)

Friday, August 8, 2014

Golf Registration October 13, 2014

Golfer Registration

Thursday, August 7, 2014

Golf Tournament October 13, 2014

Golf_Flyer[1]2014 Click to view flyer! $150 a golfer at Running Deer Golf Course

Wednesday, February 12, 2014

South Jersey Women Making a Difference- For POWCOR Pancreatic Cancer Fund

blog_image An up and coming new women's group --- South Jersey Women Making a Difference --- recently informed us about themselves and to let us know that POWCOR had been selected to receive a monetary award. Spokeswoman Deborah Klaszky explained that the group, all professional women from various parts of the state, just formed in January. They meet once a month to not only have fun but also to try, as their name implies, to make a difference by giving back to the South Jersey community. Each member contributes money at the beginning of the evening, then has the opportunity to nominate a person or group she has a personal interest in and who has need for such a contribution. By evening's end, a nominee is chosen to receive the money collected. We were the fortunate recipients this month, and the group invited us to their July meeting to receive the prize, in this case a check for $110.00. We certainly appreciate the thoughtfulness of South Jersey Women Making a Difference in selecting POWCOR and wish all the best for them. Needless to say, their donation will be put to good use in our effort to raise money for pancreatic cancer research!  

Tuesday, February 11, 2014

Welcome 2012

It's been quite some time since we've posted on our blog, but we are so excited to announce our upcoming event at the Camden Riversharks Baseball Stadium!  The event will take place May 5, 2012!  While the date has been set, there is much more information coming your way!  We've also received the latest news from the Sidney Kimmel Comprehensive Cancer Center and their most current research and findings.  Keep a look out for these updates, our event flyer coming very soon, and tickets being sold on or website for our May 5th event.  We would also like to thank those who came out and made our annual golf tournament a huge success.  We are incredibly grateful for your support.

Tuesday, February 11, 2014

Over the months…

Many of you have asked questions about our annual banquet fundraiser we usually have at a bar/restaurant in the Cherry Hill area of NJ this time of year.   While it did not happen this year, we want to assure you that Powcor is back in full swing.  For those of you that don't know, my (Rebecca's) father passed away this year from pancreatic cancer.  As the past months have been difficult, we continue to work toward raising money for Johns Hopkins current research and steps closer toward finding a vaccine for pancreatic cancer. For those of you just coming on to learn about Powcor, we want you to know how passionate we are about this cause.  As best friends, we understand each other's sadness and pain that this cancer has brought to both of our families.  Perhaps you know someone who is currently battling this awful cancer, you want to honor someone who has passed away, or you simply want to help out a good cause.  No matter what the reason, we're so grateful for your support.  Some days seem impossible when you have to face coming to terms with what this cancer has done to someone you love.  We're not giving up the fight, and we hope you'll support us in winning it.  

Tuesday, February 11, 2014

TV Industry Foundation Picks Hopkins Scientists For Cancer Research “Dream Teams”

A TV industry- and celebrity-driven cancer research project has chosen scientists at Johns Hopkins for two of five multi-institutional "dream teams" financed by "Stand Up To Cancer" grants totaling more than $6 million.
The grants, established by the Entertainment Industry Foundation, are funded with $73.6 million raised during a simultaneous, primetime, television broadcast on ABC, CBS, and NBC television networks last September.
Two awards to Johns Hopkins- led teams were chosen by a 20-member panel of scientists, physicians and patient advocates who reviewed 237 applications.
The Johns Hopkins research will focus on pancreatic cancer and epigenetics, a relatively new field of research directed at understanding and manipulating gene alterations that can shut down natural cancer protection.
Stephen Baylin, M.D., deputy director of the Sidney Kimmel Comprehensive Cancer at Johns Hopkins, will co-lead with Peter A. Jones, Ph.D., D.Sc., director of the University of Southern California/Norris Comprehensive Cancer Center a $9.12 million, three-year grant to study epigenetic changes that modify the way a cell packages its DNA sequence for regulating gene function. Abnormal DNA packaging silences genes that confer cancer protection in people with lung, breast and colon cancers. The Johns Hopkins-USC-led Dream Team will conduct legal trials and laboratory investigations to test potential treatments to reverse this silencing of genes.
"We will be looking for signatures in the genomes of tumor cells from patients with leukemia, lung, breast and colon cancer that can predict whether cancers in certain patients are susceptible to these therapies," says Baylin, who is the Virginia & D.K. Ludwig Professor in Cancer Research. "Tracking the signatures can also help monitor patients' response to the drug."
Johns Hopkins scientists will receive approximately $3 million for its portion of the epigenetics grant. Other institutions in the epigenetics dream team are the University of Pittsburgh, the University of Texas MD Anderson Cancer Center, and the Lovelace Respiratory Research Institute at the University of New Mexico. Johns Hopkins team members are: Nita Ahuja, M.D., Nilofer Azad, M.D., Malcolm Brock, M.D., Robert Casero, Jr., Ph.D., Leslie Cope, Ph.D., Edward Gabrielson, M.D., James Herman, M.D., Rosalyn Juergens, M.D., William Matsui, M.D., Charles Rudin, M.D., Ph.D., Vared Stearns, M.D., Jeff Wang, Ph.D., and Cynthia Zahnow, Ph.D.
For pancreatic cancer research, scientists at Johns Hopkins will be awarded $3.75 million in Stand Up to Cancer grants, plus clinical trial funding from the $18 million grant led by Craig Thompson, M.D., director of the Abramson Cancer Center at the University of Pennsylvania and Daniel Von Hoff. M.D., physician-in-chief and director of the Clinical Translational Research Division at the Translational Genomics Research Institute (TGen) and Chief Scientific Officer at Scottsdale Healthcare.
Johns Hopkins investigators will use their funds to test and develop drugs that target faulty enzymes that process glutamine and glucose and fatty acids in some pancreatic cancers. "There are some drugs already approved for diabetic management that have evidence of antitumor effects," says Chi Dang, M.D., Ph.D., vice dean for research at the Johns Hopkins University School of Medicine and advisor for the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins. "These drugs could be combined with other therapies currently being tested for pancreatic cancer."
In addition to Dang, the pancreatic cancer research team includes Manuel Hidalgo, M.D., Ph.D., Ralph Hruban, M.D., Kenneth Kinzler, Ph.D., Daniel Laheru, M.D., Anirban Maitra, M.D., Martin Pomper, M.D., Ph.D., and Victor Velculescu, M.D., Ph.D., from the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins, and David L. Vander Jagt, Ph.D. of the University of New Mexico.
Velculescu and Kinzler at Johns Hopkins will scan patients' genomes for genes that could benefit from glutamine and glucose-blocking drugs. Hidalgo and Maitra plan to track drug response. "We also will be looking for experimental drugs, not currently FDA-approved, which could have the same blocking effect on glucose and glutamine metabolism," says Dang, professor of medicine, cell biology, oncology and pathology.